Stock NEU NEURON BIO, S.A.
Add to a list
To use this feature you must be a member
Log inSign up

All News Neuron Bio, S.A.

Equities

NEU

ES0166198012

End-of-day quote BME
Other stock markets
 		5-day change 1st Jan Change
- EUR -.--% Intraday chart for Neuron Bio, S.A. -.--% -.--%
2017 Neuron BioLabs, S.L. cancelled the acquisition of diagnostics operations, R&D services and patents of Alzheimer's disease from Neuron Bio, SA. CI
2017 Neol Biosolutions Seeks Investors CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Neuron BioLabs, S.L. cancelled the acquisition of diagnostics operations, R&D services and patents of Alzheimer's disease from Neuron Bio, SA.
CI
Neol Biosolutions Seeks Investors
CI
Neuron Bio, S.A. Auditor Raises 'Going Concern' Doubt
CI
Neuron Bio, SA completed the acquisition of 26.28% stake in NEOL Biosolutions, S.A..
CI
Neuron Bio, SA made an offer to acquire remaining 30.22% stake in NEOL Biosolutions, S.A. for €3.4 million.
CI
Neuron BioLabs, S.L. agreed to acquire diagnostics operations, R&D services and patents of Alzheimer's disease from Neuron Bio, SA for €9 million.
CI
Neuron Bio, SA Auditor Raises 'Going Concern' Doubt
CI
NEOL Biosolutions, S.A. has completed an IPO in the amount of €1.55 million.
CI
NEOL Biosolutions, S.A. has filed an IPO in the amount of €1.55 million.
CI
Neuron Bio, SA Auditor Raises 'Going Concern' Doubt
CI
Neuron Bio, SA acquired 50% stake in NEOL Biosolutions, S.A. from Repsol, S.A. for €4.5 million.
CI
Neuron Biopharma, S.A. Auditor Raises 'Going Concern' Doubt
CI
Neuron Biopharma, S.A. Auditor Raises 'Going Concern' Doubt
CI
Repsol New Energy Ventures, S.A. acquired 50% stake in NEOL Biosolutions from Neuron BPh.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NEU Stock
  4. News Neuron Bio, S.A.